trifluridine/tipiracil and bevacizumab combination shows prolonged pfs compared to trifluridine/...
Published 6 months ago • 76 plays • Length 4:29Download video MP4
Download video MP3
Similar videos
-
1:24
bevacizumab improves efficacy of trifluridine/tipiracil (tas-102) in patients with chemorefracto...
-
1:06
comment: ftd/tpi bev ftd/tpi provides benefits for metastatic colorectal cancer patients
-
6:00
ftd/tpi bev and ftd/tpi provides benefits for metastatic colorectal cancer patients
-
3:07
trifluridine/tipiracil: a review in metastatic gastric cancer
-
3:08
trifluridine/tipiracil: benefit vs risk
-
0:43
onilon: trifluridine/tipiracil with nanoliposomal irinotecan in advanced crc
-
4:30
trifluridine/tipiracil in advanced colorectal cancer
-
10:03
panel discusses treatment for later-line crc: trifluridine/tipiracil and regorafenib
-
3:53
when you have decided to prescribe trifluridine/tipiracil
-
2:52
colorectal cancer: patient follow-up with trifluridine/tipiracil
-
2:52
metastatic colorectal cancer: trifluridine/tiripacil or regorafenib?
-
4:16
fire-3 study: cetuximab versus bevacizumab in metastatic colorectal cancer
-
5:46
alexandria study: tas-102 plus bevacizumab in patients...
-
3:08
tags: trifluridine/tipiracil in metastatic gastric adenocarcinoma
-
2:01
qol analyses from rationale-301 of tislelizumab vs sorafenib in hcc
-
3:36
cisplatin /- veliparib in metastatic tnbc and/or germline brca-associated breast cancer
-
4:25
fire-4.5: folfoxiri plus either bevacizumab or cetuximab in mcrc
-
2:48
immunomodulatory effects of parp inhibition in brca1-deficient triple-negative breast cancer